Seeking Alpha

Cepheid (CPHD) guides Q3 sales lower, saying revenue is expected to be in the range of $79M to...

Cepheid (CPHD) guides Q3 sales lower, saying revenue is expected to be in the range of $79M to $81M, lower than targeted due to intermittent interruptions in the supply of Xpert cartridge parts. The parts availability is being addressed and Cepheid is working aggressively to ship orders.  However, the company currently expects to exit the quarter with more than $5M in backorders which it expects to be fulfilled by the end of October. Shares -3% AH.
Comments (1)
  • LooseChange
    , contributor
    Comments (79) | Send Message
     
    Ahhh Ha! I'm first in line but have nothing intelligent to say at the moment. So, being new here, I'll go into the "tell people something about myself" mode.

     

    I'm a retired ceramic engineer, and my wife and I (she's an RN) are both interested in biotechnology, especially if we can learn more about CPHD without having to get sick to do that. BTW we own only a modest amount of CPHD. (We've been considering buying Ohio before Nov 6th.)

     

    Let's get a conversation going here.
    26 Sep 2012, 11:30 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|